Atlas Trials

Platinum-Sensitive Ovarian Cancer in First Relapse

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Platinum-Sensitive Ovarian Cancer in First Relapse

RecordFirmDate
A Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Participants With Low CA125 Platinum-sensitive Ovarian Cancer (NCT02289950)Eisai Inc.2015-03-19

Track Platinum-Sensitive Ovarian Cancer in First Relapse automatically

Every clearance here is in the API, with alerts when new ones post.